SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

HESTER BIOSCIENCES

BSE: 524669 30 Sep 2025
Healthcare
₹ 2055
Hester Biosciences Ltd specializes in Pharmaceuticals within the Healthcare sector.

HESTER BIOSCIENCES - Share Price & Details

Market Cap
₹1,635
High /Low
2,786 / 1,243
Stock P/E
43.5
Book Value
₹369.0
Dividend Yield
0.36
ROCE
9.71
ROE
₹9.18
Face Value
10.0
PEG Ratio
-4.01
EVEBITDA
₹24.4
Debt
213
CMP / FCF
353.0
Debt to equity
₹0.68
NP Ann
28.8
High price all time
3,379
Piotroski score
₹8.0
Graham Number
606.0
No. Eq. Shares
0.85
Net CF
₹-6.72
Net profit
38.6
Price to book value
5.2
Interest Coverage
₹6.17
Low price all time
28.7
Industry PE
33.0
Reserves
₹306
Free Cash Flow
₹44.2

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
HESTER BIOSCIENCES LTD.644.3678.38634.99.211,63543.5
Tarsons Products Limited758.635.7712.790.67163559.4
SYNCOM FORMULATIONS (INDIA) LT1225.67157.291165.470.21155927.1

Peer Comparison Chart


About HESTER BIOSCIENCES

Hester Biosciences Ltd, with Security Code 524669, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Veterinary vaccine firms form association for collaboration with policymakers

(26 Sep 2025)
New Delhi, Sep 26 (PTI) Veterinary vaccine companies, such as Hester Biosciences, Indian Immunologicals and Biovet, have come together to...
Read more →

Hester Biosciences Faces Mixed Financial Signals Amid Strong Quarterly Profit Growth

(22 Sep 2025)
Hester Biosciences has experienced a recent evaluation adjustment, reflecting a shift in its technical indicators.
Read more →

Hester Biosciences Faces Mixed Technical Trends Amid Market Evaluation Revision

(22 Sep 2025)
Hester Biosciences, a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently revised its evaluation amid market challenges.
Read more →

Hester Biosciences Shows Strong Profit Growth Amid Ongoing Financial Challenges

(11 Sep 2025)
Hester Biosciences has experienced a recent evaluation adjustment, reflecting a more favorable outlook amid strong financial performance.
Read more →

Hester Biosciences Faces Financial Challenges Amidst Strong Profit Growth and Stock Underperformance

(02 Sep 2025)
Hester Biosciences has experienced a recent evaluation adjustment due to shifts in its financial metrics and market position.
Read more →

Hester Biosciences Outperforms Sector Amid Broader Market Gains and Positive Trends

(25 Aug 2025)
Hester Biosciences has demonstrated strong performance today, with a notable intraday high and significant gains, outperforming its sector.
Read more →